4116.TWO

Strong BuyFull HouseFLAG

BenQ Medical Technology Corporation · Healthcare · Taiwan · $56M · Avg Vol: $31K/d

Full House: Strong business, sensible price, market agrees. The rare full house.

96
StockRank
Get insider-trade alerts
Quality
63
Value
82
Momentum
59
P/E (TTM)
14.9x
peers 15.7x
ROE
13.0%
peers 4.1%
D/E
0.9x
peers 0.1x
Dividend %
5.1%
trailing yield
Director trades · 180d
None →
Buybacks · 180d
None →
AI CONVICTION THESIS

BenQ Medical has quality Q62 and value V78, but momentum at M35 is well below the calibrated floor, so stage one fails.

The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.

ABOUT BENQ MEDICAL TECHNOLOGY CORPORATION

Read

BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments.

FINANCIAL SUMMARY (TWD)

Year20212022202320242025CAGRTTM
Revenue—4.4B4.5B4.8B5.3B6.3%5.4B
EPS (TWD)0.654.042.572.351.7528.2%2.64
Shares—44.6M44.6M44.6M44.6M0.0%44.6M
Debt—1.1B1.6B1.9B2.0B21.2%2.0B
Equity—1.5B1.1B1.1B1.1B-8.9%—
Op CF—482.8M442.3M222.2M358.8M-9.4%403.6M
Inv CF—-125.5M-279.0M-133.2M-79.8M——
Fin CF—-93.6M-312.6M-61.4M-191.2M——
Loading 1Y...
PRICE (1Y)-1.0%
1.231.241.251.261.27Aug 10Aug 31Sep 18
SMA 50SMA 200

Close
$1.24
RSI (14)
37.7
52W High
$1.51
From 52W High
0.8%

SCORE BREAKDOWN

Quality
63
ROIC
11.9%75.9
ROE
13.0%78.1
GP/Assets
32.5%68.1
Op. Margin
6.3%55.6
FCF/Assets
4.8%68.9
Piotroski
783.9
Int. Cover
8.5x59.7
D/E Ratio
0.88x16.6
Current Ratio
1.52x26.8
Value
82
P/E (TTM)
14.9x72.8
EV/EBITDA
7.8x80.0
P/FCF
6.9x90.1
P/B
1.6x69.6
P/S
0.3x95.8
Div Yield
5.1%89.1
Momentum
59
52W High %
82%72.0
RS 6M
-35%25.7
SMA 50/200
1.01x57.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
505%96.6

FUNDAMENTALS

Market Cap
$56M
P/E (Forward)
—
Gross Margin
32.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 4116.TWO are excluded.

TickerCompanyMkt CapStockRankSignal
4116.TWOBenQ Medical Technology Corporation(you)$56M96Strong Buy
6527.TWOCrystalvue Medical Corporation$60M85Strong Buy
1752.TWNang Kuang Pharmaceutical Co., Ltd.$102M88Strong Buy
1783.TWMaxigen Biotech Inc.$115M89Strong Buy
546.SIMedtecs International Corporation Limited$55M74Buy
4126.TWOPacific Hospital Supply Co., Ltd$178M96Strong Buy
4107.TWOBioteque Corporation$250M98Strong Buy
4771.TWVizionfocus Inc.$383M91Strong Buy
6782.TWVisco Vision Inc.$481M99Strong Buy
1565.TWOSt.Shine Optical Co.,Ltd.$156M67Buy

Peer medians: ROE 4.1% · P/E 15.7x · Gross margin 42.2%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

BenQ Medical Technology Corporation (4116.TWO): Stock Score Summary

BenQ Medical Technology Corporation (4116.TWO) has a MoatMap StockRank of 96/100 based on Quality (63/100), Value (82/100), and Momentum (59/100) factor scores. The current signal is STRONG BUY. BenQ Medical has quality Q62 and value V78, but momentum at M35 is well below the calibrated floor, so stage one fails.

BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments.

Key Financial Metrics

Price$1.24
Market Cap$56M
P/E (TTM)14.92
Price/Book1.59
Return on Equity13.0%
Return on Invested Capital11.9%
Debt/Equity0.88x
Gross Margin32.5%
Operating Margin6.3%
Revenue Growth7.1%
Dividend Yield5.1%
Free Cash Flow$8M

BenQ Medical Technology Corporation operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is BenQ Medical Technology Corporation’s (4116.TWO) StockRank?
MoatMap’s StockRank for BenQ Medical Technology Corporation (4116.TWO) is 96/100, with a Strong Buy signal. It is a composite of Quality (63), Value (82), and Momentum (59) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does BenQ Medical Technology Corporation have an economic moat?
BenQ Medical Technology Corporation (4116.TWO) has a Quality factor score of 63/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is BenQ Medical Technology Corporation a buy, hold, or sell?
MoatMap’s current signal for BenQ Medical Technology Corporation (4116.TWO) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is BenQ Medical Technology Corporation in?
BenQ Medical Technology Corporation (4116.TWO) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Taiwan).
Browse all ranked stocks4116.TWO deep dive reportAI ChampionsHow we score stocksSense-check another stock